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Tumor Necrosis Factor-a- and IL-4-Independent
Development of Langerhans Cell-Like Dendritic Cells
from M-CSF-Conditioned Precursors
Jean-Baptiste Barbaroux1,2, Wing-Hong Kwan1, Jean-Pierre Allam3, Natalija Novak3, Thomas Bieber3,
Wolf H. Fridman1, Richard Groves2 and Chris G. Mueller1
GM-CSF and transforming growth factor b (TGFb ) are required for the generation of Langerhans cells (LC),
members of the dendritic cell (DC) family. Tumor necrosis factor a (TNFa) and IL-4 can enhance LC
differentiation from human monocytes or CD34þ progenitors. Here, we show that M-CSF-cultured DC
precursors derived from CD34þ progenitors resemble dermal CD14þ cells and readily convert to LC-like DC in
GM-CSF/TGFb. The cells express Langerin, CD1a, and CCR6, migrate in response to CCR6 ligand CCL20, and
contain Birbeck granules. TNFa and IL-4, added separately or together, have an inhibitory effect on LC
differentiation. Cells differentiated in the presence of IL-4 and TNFa express low levels of CCR7. This suggests
that M-CSF-conditioned DC precursors retain the capacity to efficiently undergo a differentiation program,
giving rise to LC-like DC solely through the effect of GM-CSF and TGFb.
Journal of Investigative Dermatology (2006) 126, 114–120. doi:10.1038/sj.jid.5700023
INTRODUCTION
Langerhans cells (LC) represent a subset of dendritic cells
(DC) found in the stratified epithelia of skin and mucosae
(Maurer and Stingl, 2001). LC express CD1a but are
distinguished from other DC by the presence of intracellular
Birbeck granules, containing the C-type lectin Langerin
(CD207) (Valladeau et al., 2000) and the cell adhesion
molecule E-cadherin, enabling tight interaction with epithe-
lial cells (Tang et al., 1993). Intra- or near-epithelial LC
express CCR6 (Charbonnier et al., 1999), the chemotactic
receptor for the chemokine CCL20 produced by epithelial
cells (Charbonnier et al., 1999; Dieu-Nosjean et al., 2000).
LC development requires transforming growth factor
b (TGFb) (Borkowski et al., 1996), and human LC can be
generated from CD34þ hematopoietic progenitors cultured
with GM-CSF, TGFb, and tumor necrosis factor a (TNFa) (Caux
et al., 1992; Strunk et al., 1996). Under these conditions, TNFa
favors the outgrowth of CD1aþ DC precursors (Caux et al.,
1992; Canque et al., 1998), which express CCR6 but no CCR7
and migrate in response to CCR6 ligand CCL20 (Dieu et al.,
1998; Charbonnier et al., 1999). In the presence of IL-4, LC
differentiation is also enhanced by TNFa; however, the cells
express CCR7 and migrate in response to CCR7 ligands CCL19
or CCL21 (Geissmann et al., 2002; Arrighi et al., 2003). The
localization of cells with LC phenotype in lymph nodes of
patients with dermatopathic lymphadenitis may be correlated
with such TNFa/IL-4-dependent differentiation pathways
(Geissmann et al., 2002). It has been shown that human dermis
contains LC precursors, which express CCR6 and CD14 and
already contain Birbeck granules (Larregina et al., 2001). Upon
culture in GM-CSF/TGFb, the cells lose CD14 and acquire
CD1a and E-cadherin. This suggests that LC development can
follow a TNFa/IL-4-independent differentiation program with
homing affinity for the epithelium or a TNFa/IL-4-driven
differentiation program with migration to draining lymph nodes.
We have previously observed that dermal CD14þ cells
express TNF-related activation-induced cytokine (TRANCE)
and TRANCE-receptor (R) (Cremer et al., 2002), members of
the TNF family that are involved in cell viability (Wong et al.,
1997). Cells that share these and other antigenic markers
with dermal CD14þ cells can be obtained by culturing day-6
CD34þ progenitor-derived CD14þ cells in M-CSF (Cremer
et al., 2002). We will refer to these cells as dermal
dendrocyte-like DC (DDL-DC) in order to distinguish them
from day-6 CD14þ cells. Recently, we have demonstrated
that DDL-DC are permissive to dengue virus and HIV
infection and can differentiate into immature DC when
cultured in GM-CSF/IL-4 (Kwan et al., 2005). Here, we
investigate further their cell plasticity and address the
question of whether DDL-DC can differentiate into LC.
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RESULTS
CD34þ hematopoietic progenitors differentiate into CD14þ
TRANCEþ TRANCE-Rþ DDL-DC
We have previously shown that day-6 CD14þ cells derived
from CD34þ progenitors can differentiate into CD14þ factor
XIIIaþ TRANCEþ TRANCE-Rþ cells in M-CSF-supplemented
culture (Cremer et al., 2002). We found that cells with
similar phenotype could also be obtained by culturing the
unseparated cell populations at day 6 in M-CSF (Figure 1a).
The mean percentage of CD14þ cells in the population
was 72% (71.7, n¼ 5). The CD14þ cells thus obtained were
immunomagnetically purified and tested for expression of
specific antigenic markers by flow cytometry. Figure 1b
shows that the cells carried markers shared with the
dermal CD14þ subset, including factor XIIIa, DC-SIGN
(CD209), but lacked CD1a and Langerin. We refer to these
cells as DDL-DC.
Differentiation of DDL-DC into CD1aþ LangerinHi cells
In order to assess the ability of DDL-DC to differentiate into
LC, we cultured the cells in GM-CSF/TGFb in the presence or
absence of IL-4 or TNFa. We monitored LC differentiation by
measuring intracellular expression of CD1a and Langerin.
Figure 2a shows that DDL-DC cultured in GM-CSF/TGFb
acquired expression of CD1a and Langerin, IL-4, and TNFa’
however, inhibited differentiation into CD1aþ LangerinHi
cells. Differentiation of DDL-DC into CD1aþ LangerinHi
cells is accompanied by loss of CD14 and DC-SIGN (data not
shown). The proportion of CD1aþ LangerinHi cells obtained
in GM-CSF/TGFb varied between donors (38.7714.4%)
but the inhibitory effects of IL-4 and TNFa were always
observed (5.373.5 and 8.372% positive cells, respectively)
(Figure 2b). We next assessed the kinetics of differentiation
by measuring CD1a and Langerin expression at 24-hour
intervals over 3 days (Figure 2c). A small population of
CD1aþ LangerinHi cells appeared at 24 hours and then
rapidly increased in the following 48 hours. The inhibitory
effect of IL-4 was observed at all time points. Cultures
allowed to proceed beyond 3 days did not markedly increase
the proportion of CD1aþ LangerinHi cells in either the
presence or absence of IL-4 (not shown).
GM-CSF/TGFb induces differentiation of CCL20-responsive
CCR6þ cells
LC precursors express CCR6, the receptor for the chemokine
CCL20, produced by epithelial cells (Dieu et al., 1998;
Charbonnier et al., 1999). We assessed CCR6 expression by
flow cytometry and response to CCL20 by Ca2 flux and cell
migration. DDL-DC lacked notable CCR6 expression, but a
24-hour incubation in GM-CSF/TGFb upregulated CCR6
(Figure 3a). Addition of IL-4 to GM-CSF/TGFb prevented
CCR6 upregulation. The Ca2 flow induced by chemokine
receptor ligation was measured in response to CCL20 and in
comparison to CCL2, the ligand for CCR2 that is widely
expressed on the myeloid lineage (Figure 3b). DDL-DC
showed weak CCL20-induced signaling (28 nM of Ca2þ ) but
a robust Ca2 flow in response to CCL2. After a 24-hour
culture in GM-CSF/TGFb, the cells increased the CCL20-
induced signaling (56.4 nM of Ca2þ ) but reduced the
response to CCL2. The cells cultured in GM-CSF/TGFb
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Figure 1. Generation of DDL-DC from CD34þ hematopoietic progenitors. (a) Schematic overview of the culture conditions to obtain CD1aþ , CD14þ , double
positive and negative cells at day 5 and a majority (72%) of CD14þ cells at day 11. (b) Phenotype analysis of CD14þ -purified DDL-DC using the indicated
antibodies. Expression of all markers was detected at the cell surface. Specific labeling is shown in black histograms and isotype controls in white histograms.
www.jidonline.org 115
J-B Barbaroux et al.
TNFa- and IL-4-Independent Langerhans Cell Development
supplemented with IL-4 showed a CCL20 response similar to
DDL-DC (32.8 nM of Ca2þ ) but with reduced CCL2 signaling.
Next, we tested the cells for migration in a CCL20
chemotactic gradient (Figure 3c). DDL-DC cultured in
GM-CSF/TGFb displayed prominent migration with a peak
response at 50 ng/ml CCL20. Using a chemokine concentra-
tion range, a bell-shaped response curve was obtained
characteristic of a chemotactic response. Cells that differ-
entiated in the presence of IL-4 did not migrate at any of the
CCL20 concentrations tested. Taken together, these data
indicate that DDL-DC differentiate into cells with features
characteristic of LC (CD1a, Langerin, CCR6 expression and
CCL20 response) in response to GM-CSF/TGFb. Addition of
IL-4 or TNFa had inhibitory effects on LC differentiation.
Effect of simultaneous presence of IL-4 and TNFa on LC
differentiation
TNFa has been shown to improve LC differentiation from
CD34þ progenitors and monocytes in conditions where IL-4
is present (Geissmann et al., 2002; Arrighi et al., 2003).
Therefore, we explored how the simultaneous presence of IL-
4 and TNFa affected the formation of LC-like DC. DDL-DC
were incubated for 3 days in GM-CSF/TGFb in the presence
or absence of TNFa or IL-4, separately or together. Figure 4a
shows flow cytometry profiles of CD1a/Langerin expression
in three experiments, Figure 4b summarizes the mean
percentage of CD1aþ LangerinHi cells (gated in panel a),
and Figure 4c the mean fluorescence index of Langerin
expression (upper right quadrant in panel a). Addition of
either TNFa or IL-4 to GM-CSF/TGFb antagonized the
formation of CD1aþ LangerinHi cells. TNFa had potent
inhibitory effects at doses as low as 500 pg/ml. The
simultaneous presence of TNFa and IL-4 led to a partial
TNFa dose-dependent restoration of CD1aþ LangerinHi cells,
but the percentage of CD1aþ LangerinHi cells was signifi-
cantly smaller, and the expression level of Langerin
remained significantly lower compared to the GM-CSF/TGFb
condition.
We next investigated expression of chemokine receptors
CCR6 and CCR7 as well as maturation markers CD86, CD83,
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Figure 2. DDL-DC differentiate into CD1aþ LangerinHi cells. DDL-DC were
cultured for 3 days in GM-CSF/TGFb, alone or in the presence of IL-4 or
TNFa. (a) Representative phenotype analysis of CD1a/Langerin expression.
(b) The percentage of CD1aþ LangerinHi cells, electronically gated as shown
in (a) and obtained in GM-CSF/TGFb in the presence or absence of 1 ng/ml
IL-4 or 1 ng/ml TNFa, is shown for each donor. Significance was evaluated
using the t-tailed Student’s test. (c) Kinetics of differentiation of DDL-DC into
CD1aþ LangerinHi cells in GM-CSF/TGFb in the presence or absence of IL-4.
The percentage of CD1aþ LangerinHi cells was measured every 24 hours for 3
days and expressed as the mean7SE of three experiments.
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Figure 3. GM-CSF/TGFb induces differentiation of CCL20-responsive
CCR6þ cells. (a) CCR6 expression of DDL-DC before and after a 24-hour
culture in GM-CSF/TGFb in the presence or absence of IL-4. Specific labeling
is shown in gray histograms and isotype controls in white histograms.
(b) Measurement of calcium flow in response to CCL20 or CCL2 ligation
expressed as nM of mobilized calcium per 106 cells. The arrow indicates
the time of chemokine addition. The cells were as in (a). The experiment
was performed twice using different donor CD34þ cells with similar results.
(c) GM-CSF/TGFb- or GM-CSF/TGFb þ IL-4-cultured DDL-DC were tested for
chemotactic migration in response to increasing concentrations of CCL20.
The number of migrated cells is expressed as the mean7SE of three
independent experiments.
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CD80, and HLA-DR. As shown in Figure 5a, the cells
generated in GM-CSF/TGFb expressed cell-surface Langerin
and CCR6 but virtually no CCR7. Addition of IL-4 induced
low levels of CCR6 and CCR7. In the presence of TNFa,
Langerinþ cells expressed CCR6 but lacked CCR7. The
simultaneous presence of IL-4 and TNFa resulted in a few
Langerinþ cells that showed similar expression of CCR6 and
CCR7 as IL-4-treated cultures. The cells cultured in the
different cytokine combinations lacked CD86, CD83, and
CD80 expression. With respect to HLA-DR, TNFa-stimulated
cultures comprised a small cell population expressing high
levels of HLA-DR. We assessed whether the cells could
respond to the dual maturation stimulus lipopolysaccharide
(LPS)/anti-CD40. As shown in Figure 5b, the cells obtained
under all conditions formed cell clusters, upregulated
CCR7, HLA-DR, CD86, CD83, and CD80 concomitant with
a decrease in cell-surface Langerin.
GM-CSF/TGFb-generated LC-like cells contain Birbeck granules
We performed transmission electron microscopy on ultrathin-
sectioned cells generated from DDL-LC in the presence of
GM-CSF and TGFb (Figure 6). Cells displayed dendritic
morphology with slightly off-centered lobulated nuclei. The
cytoplasm was devoid of multivesicular organelles typical of
mononuclear macrophages, but contained Birbeck granules,
cytoplasmic organelles forming a rod-shaped structure with
double membrane junctions (Figure 6, inset) (Caux et al.,
1992). More open-ended tennis-racket-shaped granules were
not seen. About 10% of the cells showed these rod-shaped
Birbeck granules.
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Figure 4. TNFa and IL-4 inhibit LC differentiation, but simultaneous addition of both cytokines diminishes their inhibitory effect. (a) DDL-DC cultured for 3
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CD1aþ LangerinHi cells for the three experiments. The CD1aþ LangerinHi cells were defined as located within the gate of (a). The doses (ng/ml) of TNFa and IL-
4 are indicated below the histograms. Significance was calculated using the t-tailed Student’s test (*Po0.05). (c) Representation of the geometric mean7SE
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Significance was calculated using the t-tailed Student’s test (*Po0.05).
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DISCUSSION
In this report, we have shown that DDL-DC, which share
phenotypic markers with the dermal CD14þ cells, readily
differentiate into LC-like DC upon culture in GM-CSF/TGFb.
The presence of either TNFa or IL-4 led to inhibition of LC
differentiation, and simultaneous addition of IL-4 and TNFa
could only partially restore LC generation.
The precursor cells were generated from CD34þ hema-
topoietic progenitors in the presence of M-CSF, which
induced loss of CD1a and acquisition of CD14. The cells,
which we refer to as DDL-DC, expressed other markers
characteristic of dermal CD14þ mononuclear phagocytes
including DC-SIGN (Turville et al., 2002), factor XIIIa (Cerio
et al., 1989), TRANCE, and TRANCE-R (Cremer et al., 2002,
Kwan et al., 2005). The data presented here show that, under
the influence of GM-CSF/TGFb, DDL-DC acquire features
typical of LC: (1) high expression of Langerin, CD1a, and
CCR6; (2) signal and migratory response to CCR6 ligand
CCL20; and (3) Birbeck granules. This supports the idea that
TGFb and GM-CSF can be sufficient for LC formation from
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Figure 5. GM-CSF/TGFb-cultured cells mature in response to LPS/anti-CD40. (a) DDL-DC cultured for 3 days in GM-CSF/TGFb in the presence or absence of
TNFa or IL-4, or in the presence of both TNFa and IL-4, were visualized by light microscopy and analyzed for expression of cell-surface Langerin versus CCR6,
CCR7, HLA-DR, CD86, CD83, and CD80. The FACS plots for CCR6, CCR7, and CD83 are representative of five experiments and, for CD86, CD80, and HLA-
DR, are representative of two experiments. (b) The same cells, as shown in (a), were stimulated for 24 hours with LPS/anti-CD40, visualized by light microscopy,
and analyzed for cell-surface marker expression. For all flow cytometry analyses, expression levels were obtained after gating on total live cells, identified by
forward and side scatter profiles.
Figure 6. Transmission electron microscopy visualizes Birbeck granules.
DDL-DC were cultured in GM-CSF/TGFb for 6 days and processed for
transmission electron microscopy. About 10/100 cells analyzed at a
magnification of  30,000 showed rod-shaped Birbeck granules (inset,
lower left).
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dermal CD14þ precursor cells (Larregina et al., 2001). GM-
CSF is required for LC formation from DDL-DC and cannot be
omitted or replaced by M-CSF (data not shown) and DDL-DC
differ from other progenitors in this manner (Larregina et al.,
2001; Mollah et al., 2003). We have also tested for the
requirement of fetal calf serum and found that differentiation
of LC-like cells did not occur in serum-free culture medium
(data not shown). The percentage of CD1aþ cells that express
high levels of Langerin was 38.7714.4%, which compares
favorably with other means of generating Langerinþ cells
from CD34þ progenitors, reported as 25% using GM-CSF/
TGFb/IL-4/TNFa (Arrighi et al., 2003) or 25710% obtained in
the presence of GM-CSF/TGFb/TNFa. In terms of cell
numbers, 106 CD34þ progenitors yield on average
30106 DDL-DC from which we obtain about 10106
CD1aþ Langerinþ cells. Similar numbers of LC-like DC were
reported when culturing CD34þ progenitors directly in GM-
CSF/TGFb/TNFa (Caux et al., 1992). The cells displayed an
immature phenotype but responded to DC maturation signal
LPS/anti-CD40 by expression of maturation markers CD80,
CD83, CD86 as well as CCR7 and HLA-DR. Maturation was
accompanied by reduction of Langerin expression, confirm-
ing observations made by others (Valladeau et al., 1999;
Geissmann et al., 2002).
Addition of IL-4 to GM-CSF/TGFb antagonized LC
differentiation and skewed DC differentiation toward the
interstitial type lacking Langerin, supporting previous ob-
servations (Caux et al., 1999; Guironnet et al., 2002).
Interestingly, in the presence of IL-4, interstitial-like DC
expressed low levels of CCR7, which may suffice to direct
cell migration to draining lymph nodes (Ohl et al., 2004).
Addition of TNFa to GM-CSF/TGFb also antagonized LC
differentiation, which could be correlated with a disposition
of these cells to differentiate into macrophages in conjunction
with the pre-culture in M-CSF. This is particularly evident at
TNFa concentrations 41 ng/ml resulting in the formation of
plastic-adherent CD11bHi macrophages (data not shown). In
this context, it has been shown that CD34þ progenitor-
derived day-6 CD14þCD11bþ cells resist differentiation into
cells with LC features upon culture in GM-CSF/TGFb/TNFa
and acquire a more macrophage-like phenotype (Jaksits
et al., 1999). The simultaneous presence of IL-4 and TNFa
could partially alleviate the inhibitory effects leading to a
limited restoration of CD1aþ LangerinHi cells. However, in
spite of different dosage combinations of IL-4 and TNFa, we
were never able to completely restore the percentage and
level of Langerin expression obtained in the GM-CSF/TGFb
condition. In addition, the Langerinþ cells obtained in
GM-CSF/TGFb/IL-4/TNFa expressed CCR7, which further
distinguished them from the cells obtained in GM-CSF/TGFb.
The dermal microenvironment contains numerous cyto-
kines and cell differentiation signals under both resting and
inflamed conditions. The cytokines that we have studied in
this work (M-CSF, GM-CSF, TGFb, TNFa, and IL-4) have all
been identified as products of dermal cell types including
endothelium, fibroblasts, and mast cells. DDL-DC are model
cells for CD14þ DC-SIGNþ cells, which reside in con-
nective tissue such as the dermis under non-inflammatory
conditions, where M-CSF is likely to be present. Even under
these conditions, LC continue to migrate to draining lymph
nodes, and we suggest that dermal CD14þ DC-SIGNþ cells
contribute to LC renewal in the steady state.
MATERIALS AND METHODS
Cell preparation
Cord blood was obtained from the Bourg-La-Reine maternity ward,
France, after informed consent. CD34þ progenitors were immuno-
magnetically isolated from umbilical cord blood and cultured for 5
days in complete medium composed of RPMI 1640 medium (Gibco-
Invitrogen, Cergy-Pontoise, France) with 10% LPS-free fetal calf
serum (Gibco-Invitrogen), supplemented with 25 ng/ml stem cell
factor (specific activity: 106 U/mg; R&D Systems, Abbington, UK),
3 ng/ml TNFa (108 U/mg; R&D Systems), and 200 U/ml GM-CSF
(107 U/mg; Schering-Plough, Kenilworth, NJ) (Caux et al., 1996;
Cremer et al., 2002). Cells were washed and DDL-DC were obtained
after 6 additional days of culture in complete medium supplemented
with 25 ng/ml M-CSF (15 107 U/mg; R&D Systems), with additional
M-CSF after 3 days. The CD14þ DDL-DC were immunomagneti-
cally purified using CD14þ -coupled magnetic beads (Miltenyi,
Bergisch-Gladbach, Germany). DDL-DC were differentiated for 3
days in complete medium with 530 U/ml of GM-CSF (Schering-
Plough) and 4 ng/ml of TGFb (3 107 U/mg; R&D Systems). Where
indicated, 1 ng/ml IL-4 (24 106 U/mg; Schering-Plough) and/or
0.5–1 ng/ml TNFa (R&D Systems) was added. Cells were matured by
incubation with 100 ng/ml LPS and 10 mg/ml anti-CD40 antibody
(G24.5) for 24 hours.
Phenotypic analysis
Expression of specific markers was determined using the following
antibodies from Becton-Dickinson-Pharmingen (Le Pont-de-Claix,
France) unless otherwise noted: CD80-FITC (RMMP2), CD86-FITC
(RMMP1), Langerin-PE (DCGM4) (Coulter-Immunotech, Villepinte,
France), HLA DR-FITC (L243), CD83-FITC (HB15e), CD1a-FITC
(HI149), CD14-FITC (MfP9), CCR6-biotin (11A9) and mouse IgM
anti-CCR7 (2H4) (followed by F[ab0]2 biotin-goat anti-mouse IgM
from Jackson Immunoresearch, West Grove, PA and streptavidin-
APC from Pharmingen), factor XIIIa (Calbiochem, San Diego, CA)
(followed by PE-goat anti-rabbit Ig from Jackson Immunoresearch),
TRANCE (R&D Systems, directly coupled to Cy3), TRANCE-R (N-20
from Santa Cruz, Santa Cruz, CA, followed by FITC-rabbit anti-goat
Ig from Jackson Immunoresearch), DC-SIGN (1B10, a kind gift of Ali
Amara, Institut Pasteur, France, followed by PE-goat anti-mouse Ig
from Jackson Immunoresearch). Specific binding was measured by
flow cytometry on a FACSCalibur (Becton-Dickinson-Pharmingen)
and analysis was performed using the CellQuest Pro software
(Becton-Dickinson).
Measurement of intracellular calcium
Cells were incubated in PBS supplemented with 10 mM HEPES,
0.5 mM MgCl2 1 mM CaCl2, 2 mM Fura-2/AM (Molecular Probes, San
Francisco, CA), and 2mM pluronic acid for 30 minutes at 371C
(5 105 cells/ml). Fura-2/AM-loaded cells were washed and resus-
pended in 2 ml of the buffer and transferred to a quartz cuvette for
measurements. Stimulation was performed using 100 mM of CCL20
and CCL2 (R&D Systems). Fluorescence was measured using a SAFAS
spectrofluorometer (SAFAS, Monaco) in cuvettes thermostatically
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controlled at 371C and continuously stirred. Results are expressed in
nM of calcium per 106 cells as a function of the ratio of fluorescence
at two excitation wavelengths (340 and 380 nm).
Chemotactic cell migration
Chemotactic cell migration was assessed using a chemotaxis Boyden
microchamber with a standard 5mm pore polycarbonate filter
(Neuroprobe, Gaithersburg, MD). DDL-DC were incubated in GM-
CSF/TGFb in the presence or absence of IL-4. After 24 hours, 105
cells were placed in the upper chamber and increasing doses of
CCL20 (R&D systems) were added to the lower chamber. After
1 hour at 371C, cells bound to the separating membrane were
washed, fixed in methanol, and stained with eosin and hematoxylin.
Membrane-bound cells of duplicates were counted.
Transmission electron microscopy
For electron microscopy, 106 LC-like DC, generated in GM-CSF/
TGFb, were fixed in cacodylate buffer containing 6% of a 25%
glutaraldehyde solution and were further processed as described
elsewhere (Hanau et al., 1987). Microscopic analysis was performed
using a Zeiss EM109 transmission electron microscope.
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